| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20067921 | HPV | ENSG00000132155.14 | protein_coding | RAF1 | Yes | No | 5894 | A0A0S2Z4L5 L7RRS6 P04049 |
| TVIS20056964 | HPV | ENSG00000132155.14 | protein_coding | RAF1 | Yes | No | 5894 | A0A0S2Z4L5 L7RRS6 P04049 |
| TVIS20013993 | HPV | ENSG00000132155.14 | protein_coding | RAF1 | Yes | No | 5894 | A0A0S2Z4L5 L7RRS6 P04049 |
| TVIS44024949 | HTLV-1 | ENSG00000132155.14 | protein_coding | RAF1 | Yes | No | 5894 | A0A0S2Z4L5 L7RRS6 P04049 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | RAF1 |
|---|---|
| DrugBank ID | DB04973 |
| Drug Name | LErafAON |
| Target ID | BE0000036 |
| UniProt ID | P04049 |
| Regulation Type | |
| PubMed IDs | 12429653 |
| Citations | Gokhale PC, Zhang C, Newsome JT, Pei J, Ahmad I, Rahman A, Dritschilo A, Kasid UN: Pharmacokinetics, toxicity, and efficacy of ends-modified raf antisense oligodeoxyribonucleotide encapsulated in a novel cationic liposome. Clin Cancer Res. 2002 Nov;8(11):3611-21. |
| Groups | Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |
